普里斯蒂米林在人类恶性瘤中的抗癌潜力和分子点
Kirti S Prabhu1, Serah Jessy1, Shilpa Kuttikrishnan1
1Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.
Pharmaceuticals (Basel, Switzerland)
|May 25, 2024
概括
普里斯蒂米林是一种天然化合物,通过影响关键细胞过程,在许多癌症类型中表现出强大的抗癌活性. 进一步的研究可能会导致其发展成为一种不那么有毒的癌症治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 全球癌症负担日益增加,需要新的,不那么有毒的治疗剂.
- 草药化合物因其潜在的抗癌疗效和减少副作用而受到越来越多的关注.
- 普里斯蒂美林 (PS) 是一种三类化合物,是一种有前途的天然化合物,具有广泛的抗瘤特性.
研究的目的:
- 综合审查关于普里斯蒂米林 (PS) 的当前文献.
- 阐明PS在癌症中的作用机制和分子点.
- 讨论PS作为未来抗癌疗法的潜力.
主要方法:
- 文献综述综合了关于普里斯蒂米林的当前研究.
- 分析PS对细胞过程的影响,如细胞亡,自,迁移,入侵,血管新生和化学抵抗.
- 确定PS针对的关键信号通路,包括NF-κB,p53和STAT3.
主要成果:
- 普里斯蒂米林 (PS) 对各种癌症 (乳腺癌,胰腺癌,前列腺癌,质母细胞瘤,结肠直肠癌,宫癌,肺癌) 具有广泛的抗瘤活性.
- PS调节关键的细胞过程,并向关键的瘤信号通路.
- 与目前的癌症疗法相比,PS具有潜在的优势,包括降低毒性.
结论:
- 普里斯蒂米林 (PS) 是一种强大的抗癌药物,具有多种作用机制.
- 了解PS的分子目标和途径为未来的研究提供了洞察力.
- PS具有显著的发展潜力,可以成为临床适用的抗癌疗法.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
00:07In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K